Literature DB >> 10030312

Serum beta-hydroxybutyrate measurement in patients with uncontrolled diabetes mellitus.

M Fulop1, V Murthy, A Michilli, J Nalamati, Q Qian, A Saitowitz.   

Abstract

OBJECTIVE: To assess whether routinely measuring serum beta-hydroxybutyrate (beta-OHB) concentration might help judge the severity of or assist in treating patients with suspected ketoacidosis.
METHODS: Serum beta-OHB level was estimated by a standard enzymatic method in 64 episodes in adults admitted to a municipal hospital. Of the 85 specimens analyzed, 60 were taken before treatment from a nearly consecutive group of diabetic patients with ketosis, 21 were follow-up specimens, and 4 were from nondiabetic patients with ketosis.
RESULTS: In the 85 specimens, the correlation between serum carbon dioxide and beta-OHB levels was -0.69, and that between anion gap and beta-OHB level was 0.75. For just the initial specimens, the respective correlation coefficients were -0.60 and 0.52.
CONCLUSIONS: The correlations between serum beta-OHB and carbon dioxide levels and the anion gap were close, but not sufficiently so for the beta-OHB measurements to be routinely useful alone to assess the severity of the ketoacidosis. Full laboratory assessment of the severity and characteristics of ketoacidosis also requires knowledge of serum carbon dioxide level, anion gap, often blood pH, and ideally serum acetoacetate and lactate concentrations as well as serum beta-OHB concentration.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10030312     DOI: 10.1001/archinte.159.4.381

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  7 in total

1.  Exploring the clinical utility of blood ketone levels in the emergency department assessment of paediatric patients.

Authors:  P B O'Donohoe; R Kessler; T F Beattie
Journal:  Emerg Med J       Date:  2006-10       Impact factor: 2.740

Review 2.  Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state.

Authors:  Jean-Louis Chiasson; Nahla Aris-Jilwan; Raphaël Bélanger; Sylvie Bertrand; Hugues Beauregard; Jean-Marie Ekoé; Hélène Fournier; Jana Havrankova
Journal:  CMAJ       Date:  2003-04-01       Impact factor: 8.262

3.  Serum ketone body measurement in patients with diabetic ketoacidosis.

Authors:  Tomonao Hirobata; Hidefumi Inaba; Yosuke Kaido; Daisuke Kosugi; Saya Itoh; Takaaki Matsuoka; Gen Inoue
Journal:  Diabetol Int       Date:  2022-04-13

4.  β-Hydroxybutyrate modulates N-type calcium channels in rat sympathetic neurons by acting as an agonist for the G-protein-coupled receptor FFA3.

Authors:  Yu-Jin Won; Van B Lu; Henry L Puhl; Stephen R Ikeda
Journal:  J Neurosci       Date:  2013-12-04       Impact factor: 6.167

5.  Butyrate increases intracellular calcium levels and enhances growth hormone release from rat anterior pituitary cells via the G-protein-coupled receptors GPR41 and 43.

Authors:  Maria Consolata Miletta; Vibor Petkovic; Andrée Eblé; Roland A Ammann; Christa E Flück; Primus-E Mullis
Journal:  PLoS One       Date:  2014-10-13       Impact factor: 3.240

6.  Comparisons of biochemical parameters and diabetic ketoacidosis severity in adult patients with type 1 and type 2 diabetes.

Authors:  Atchara Charoenpiriya; Laor Chailurkit; Boonsong Ongphiphadhanakul
Journal:  BMC Endocr Disord       Date:  2022-01-06       Impact factor: 2.763

7.  Pathway of programmed cell death and oxidative stress induced by β-hydroxybutyrate in dairy cow abomasum smooth muscle cells and in mouse gastric smooth muscle.

Authors:  Wulin Tian; Teng Wei; Bin Li; Zhe Wang; Naisheng Zhang; Guanghong Xie
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.